Cargando…
TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling
BACKGROUND: TLN-4601 is a structurally novel farnesylated dibenzodiazepinone discovered using Thallion's proprietary DECIPHER(® )technology, a genomics and bioinformatics platform that predicts the chemical structures of secondary metabolites based on gene sequences obtained by scanning bacteri...
Autores principales: | Campbell, Paul M, Boufaied, Nadia, Fiordalisi, James J, Cox, Adrienne D, Falardeau, Pierre, Der, Channing J, Gourdeau, Henriette |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990749/ https://www.ncbi.nlm.nih.gov/pubmed/21044336 http://dx.doi.org/10.1186/1750-2187-5-18 |
Ejemplares similares
-
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
por: Gillies, Taryn E, et al.
Publicado: (2020) -
Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele
por: Sakurada, Kumi, et al.
Publicado: (2018) -
An integrin binding motif in TLN-1/talin plays a minor role in motility and ovulation
por: Sadeghian, Fereshteh, et al.
Publicado: (2023) -
TLN1 contains a cancer-associated cassette exon that alters talin-1 mechanosensitivity
por: Gallego-Paez, Lina M., et al.
Publicado: (2023) -
The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C
Publicado: (1996)